Why the study?
Whether exercise stress testing for early CAD identification should be performed for pre-participation screening in all master athletes or only in high-risk athletes remained debated.
What is the prevalence of moderate-to-severe coronary artery disease and concealed arrhythmogenic substrates on CCTA and CMR among asymptomatic master athletes with ST-segment depression or high-risk premature ventricular beats during preparticipation exercise testing?
What is the prevalence of moderate-to-severe coronary artery disease and concealed arrhythmogenic substrates on CCTA and CMR among asymptomatic master athletes with ST-segment depression or high-risk premature ventricular beats during preparticipation exercise testing?
In asymptomatic master athletes, exercise-induced ST-segment depression and high-risk premature ventricular beats have a low positive predictive value (13%) for ≥50% coronary stenosis—which occurs exclusively in those with traditional cardiovascular risk factors—though exercise testing remains valuable for uncovering non-ischemic arrhythmogenic substrates like myocardial scar in 43% of athletes with PVBs.
Answers are grounded in this paper and cite their sources.
CCTA after positive ET detects CAD in 38% of master athletes; leaves open whether universal PPS ET improves outcomes over risk-based strategies.
Aims Whether exercise stress testing (ET) for early identification of coronary artery disease (CAD) should be performed for preparticipation screening (PPS) in all master athletes (MAs) or in high-risk athletes only remains debated. We evaluated the prevalence and characteristics of CAD in MAs who underwent coronary computed tomography angiography (CCTA) after a positive preparticipation ET. Methods and results According to Italian law and guidelines, all MAs ≥40 years old must undergo annual ET as part of PPS. We retrospectively enrolled MAs without symptoms, baseline ECG abnormalities or history of heart disease referred to CCTA for ST-segment depression (STD) and/or high-risk premature ventricular beats (PVBs) during ET. We evaluated CAD burden, plaque characteristics, and pericoronary fat attenuation index. Athletes with at-risk PVBs also underwent cardiac magnetic resonance (CMR). We enrolled 130 Caucasian MAs (84% males, median age 54 years): 49 (37%) with high-risk PVBs, and 82 (62%) with STD. Coronary artery disease with ≥50% stenosis was identified in 17 (13%) MAs, including 1 with high-risk plaques, without differences according to CCTA indications (P = 0.83). Age ≥ 60 years and dyslipidemia were independent predictors of ≥50% stenosis, and none of the 45 athletes without risk factors had CAD. Only three athletes eventually required coronary revascularization. Among MAs with PVBs, 20/49 (41%) had abnormal CMR and one cathecolaminergic polymorphic ventricular tachycardia. Conclusion In a sample of asymptomatic MAs, STD and PVBs during ET were poor predictors for the presence of significant CAD, strongly influenced by the presence of traditional cardiovascular risk factors. However, ET may have a broader diagnostic value by identifying exercise-induced PVBs, enabling the detection of concealed arrhythmogenic conditions.
No takes yet. Share an insight, caveat, or question.
Graziano et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: